Artrya
Artrya Limited is a cutting-edge medical technology company specializing in software that automates the analysis of heart CT scans to aid in the diagnosis of Coronary Artery Disease. Positioned as an innovator in healthcare AI solutions, Artrya focuses on providing accurate, non-invasive diagnostic tools that enhance patient care outcomes. Their offerings are particularly valuable in improving the detection efficiency and accuracy of coronary artery disease assessments.
Short position
Artrya (ASX:AYA) has 8.55% of its shares on issue reported as short positions as of 5 Oct 2026, or about 13,978,278 shares. Over the past 30 days that figure has risen 6.19 percentage points, and over 90 days it has risen 7.64 percentage points. AYA is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Artrya (AYA) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $28.0Kvs $28.0K (FY25)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- −$25.2Mvs −$16.4M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- −$0.17T (source: Derived: trailing 12 months at year end)vs −$0.18 (FY25)
- Derived: trailing 12 months at year end, as at 29 Sep 2026
- Rev YoY
- 0.0%FY
- EPS YoY
- n/aTTM
- Derived: trailing 12 months at year end
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 9 Oct 2026
- Gross margin
- 100.0%
- Operating margin
- −118,710.7%
- Net margin
- −89,939.3%
- FCF margin
- −65,910.7%
- ROE
- −50.6%
- ROA
- −46.2%
- FCF conversion
- n/a
- Net cash (excl. leases)
- $44.0M
- Net debt / EBITDA
- n/a
- Current ratio
- 15.7×
- Interest cover
- n/a
- Cash dividends paid / net profit
- n/a
- Market cap
- $490.5M
- P/E
- n/a
- P/B
- 6.3×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $28.0K | $28.0K | n/a | n/a |
| Gross profit | $28.0K | $28.0K | n/a | n/a |
| Operating income | −$33.2M | −$22.1M | −$18.0M | −$12.4M |
| EBITDA | −$32.0M | −$20.9M | −$16.1M | −$11.9M |
| EBIT | −$33.2M | −$22.1M | −$18.0M | −$12.4M |
| Pretax income | −$25.2M | −$16.4M | −$14.0M | −$11.1M |
| Tax | $1.0K | $29.0K | $27.0K | $18.0K |
| NPAT | −$25.2M | −$16.4M | −$14.0M | −$11.1M |
| Net interest income | $2.4M | $241.0K | $427.0K | $346.0K |
| EPS basic | −$0.17T (source: Derived: trailing 12 months at year end) | −$0.18 | −$0.18 | −$0.14 |
| EPS diluted | −$0.17T (source: Derived: trailing 12 months at year end) | −$0.18 | −$0.18 | −$0.14 |
| Shares | 163.0M | 113.4M | 78.7M | 78.5M |
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- FY26 Financial Results and Operational Update PresentationFinancial Report1 Sep 2026via asx_announcements
- Appendix 4E and Annual Report to ShareholdersAnnual Results19 Aug 2026via asx_announcements
- June Quarterly Activities Report and Appendix 4CQuarterly Report29 Jul 2026via asx_announcements
- March Quarterly Activities Report and Appendix 4CQuarterly Report30 Apr 2026via asx_announcements
- Appendix 4D and Interim Financial ReportHalf Year Results25 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Jan 2026via asx_announcements
- Read MoreFinancial Report31 Dec 2025via smart_crawler
- Read MoreFinancial Report31 Dec 2025via smart_crawler
- Read MoreFinancial Report31 Dec 2025via smart_crawler
- Read MoreFinancial Report31 Dec 2025via smart_crawler
Showing 10 of 56 reports